Are Investors Undervaluing Host Hotels & Resorts (HST) Right Now? — Positive
HST Zacks Investment Research — January 12, 2026Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced — Positive
INSM Zacks Investment Research — January 12, 2026Shares of Insmed rise after it tops FY25 sales forecasts, led by strong Brinsupri uptake, and outlines 2026 guidance and pipeline milestones.
Can Estee Lauder's Fragrance Strength Drive Top-Line Growth? — Positive
EL Zacks Investment Research — January 12, 2026EL sees fragrance emerge as its strongest category, helping drive a return to positive organic sales growth in the fiscal first quarter.
Exelixis Posts Preliminary '25 Results, Issues '26 Outlook — Neutral
EXEL Zacks Investment Research — January 12, 2026EXEL posts approximately $2.32B in 2025 revenues and guides $2.525 -$2.625B for 2026 as Cabometyx grows and a zanzalintinib NDA advances.
SMCI Plunges 45% in 3 Months: Time to Buy, Sell or Hold the Stock? — Neutral
SMCI Zacks Investment Research — January 12, 2026Super Micro Computer shares are down nearly 45% in three months, trading at a discounted P/E as margins compress, cash flow weakens, and AI expansion drives a Hold view.
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) — Positive
ANGO Zacks Investment Research — January 12, 2026AngioDynamics (ANGO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround — Positive
AQST Zacks Investment Research — January 12, 2026Aquestive Therapeutics (AQST) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
SharkNinja, Inc. (SN) Presents at ICR Conference 2026 Transcript — Neutral
SN Seeking Alpha — January 12, 2026SharkNinja, Inc. (SN) Presents at ICR Conference 2026 Transcript
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment — Neutral
DVLT Accesswire — January 12, 2026On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports …
TORONTO, Jan. 12, 2026 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces three of many new Club Offers for Club Members in Canada. Rigorously vetted and negotiated for us travel enthusiasts: $1299—MADRID & BARCELONA: 6 NIGHTS W/FLIGHTS Take in the art, culture and gastronomy of Spain's most iconic cities.
The 3 Vanguard ETFs With The Highest Dividend Yields — Positive
VCLT VGHY VWOB 24/7 Wall Street — January 12, 2026Vanguard is a favorite for many investors, thanks to its wide portfolio of index funds with very low expenses.
Altria's Discount Strategy: Is Basic Brand a Smart Move for It? — Neutral
MO Zacks Investment Research — January 12, 2026MO shifts its cigarette mix toward lower-priced options as consumers become more price-conscious, helping cushion volume pressure in a challenging market.
Amphenol (APH) Crossed Above the 50-Day Moving Average: What That Means for Investors — Positive
APH Zacks Investment Research — January 12, 2026Amphenol (APH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, APH broke out above the 50-day moving average, suggesting a short-term bullish trend.
Earnings Growth & Price Strength Make CBRE Group (CBRE) a Stock to Watch — Positive
CBRE Zacks Investment Research — January 12, 2026Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Brokers Suggest Investing in APTIV HLDS LTD (APTV): Read This Before Placing a Bet — Negative
APTV Zacks Investment Research — January 12, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Is It Worth Investing in SkyWater Technology (SKYT) Based on Wall Street's Bullish Views? — Neutral
SKYT Zacks Investment Research — January 12, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Wall Street Bulls Look Optimistic About Clear Secure (YOU): Should You Buy? — Positive
YOU Zacks Investment Research — January 12, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True? — Neutral
CRSP Zacks Investment Research — January 12, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Should You Invest in Gray Media (GTN) Based on Bullish Wall Street Views? — Neutral
GTN Zacks Investment Research — January 12, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Wall Street Analysts Think CleanSpark (CLSK) Is a Good Investment: Is It? — Positive
CLSK Zacks Investment Research — January 12, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?